Neoadjuvant therapy for resectable pancreatic cancer: a critical reappraisal of contemporary evidence and clinical decision-making—a narrative review
Annals of Pancreatic Cancer · 2026-11 · 9 · 29-29
DOI: 10.21037/apc-26-0030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pancreatic Cancer, 2026-11. Verfasst von Takehiro Okabayashi und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Okabayashi, T., Tabuchi, M., Tokumaru, T., Uemura, S., & Tamura, S. (2026). Neoadjuvant therapy for resectable pancreatic cancer: a critical reappraisal of contemporary evidence and clinical decision-making—a narrative review. Annals of Pancreatic Cancer, 9, 29-29. https://doi.org/10.21037/apc-26-0030
Vancouver
Okabayashi T, Tabuchi M, Tokumaru T, Uemura S, Tamura S. Neoadjuvant therapy for resectable pancreatic cancer: a critical reappraisal of contemporary evidence and clinical decision-making—a narrative review. Annals of Pancreatic Cancer. 2026;9:29-29. doi:10.21037/apc-26-0030
BibTeX
@article{Okabayashi2026,
author = {Okabayashi, Takehiro and Tabuchi, Motoyasu and Tokumaru, Teppei and Uemura, Sunao and Tamura, Shuta},
title = {Neoadjuvant therapy for resectable pancreatic cancer: a critical reappraisal of contemporary evidence and clinical decision-making—a narrative review},
journal = {Annals of Pancreatic Cancer},
year = {2026},
volume = {9},
pages = {29--29},
doi = {10.21037/apc-26-0030}
}
EUVIMED